MS
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies | Molecular psychiatry |  | 2025 | 267 | 170 | ||
| Mindfulness-based interventions for patients with schizophrenia spectrum disorders : A systematic review of the literature | Schizophrenia research | | 2024 | 97 | 389 | ||
| Psychédéliques : entre usage thérapeutique et usage récréatif | Bulletin des médecins suisses | | 2024 | 254 | 138 | ||
| Psychothérapie assistée par psychédéliques (PAP) : le modèle genevois | Annales médico-psychologiques | | 2024 | 388 | 801 | ||
| Evidence-based approach for treatment of negative symptoms of schizophrenia | | 2023 | 121 | 169 | |||
| Half a century of research on Attention-Deficit/Hyperactivity Disorder: A scientometric study | Neuroscience and biobehavioral reviews | | 2022 | 256 | 601 | ||
| A century of research on psychedelics : A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs | European neuropsychopharmacology | | 2022 | 64 | 90 | ||
| No increase in burnout in health care workers during the initial COVID-19 outbreak: Systematic review and meta-analysis | World journal of meta-analysis | | 2022 | 268 | 348 | ||
| EPA guidance on assessment of negative symptoms in schizophrenia | European Psychiatry | | 2021 | 350 | 1,236 | ||
| EPA guidance on treatment of negative symptoms in schizophrenia | European Psychiatry | | 2021 | 315 | 607 | ||
| Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials | NPJ schizophrenia | | 2021 | 279 | 618 | ||
| Suicide in psychiatry and medical liability: A case series | International Journal of Law and Psychiatry |  | 2021 | 242 | 0 | ||
| Toxicity of psychotropic drugs in patients with COVID-19: A systematic review | General Hospital Psychiatry | | 2021 | 316 | 1,474 | ||
| A systematic review and meta-analysis of the prevalence of cocaine-induced psychosis in cocaine users | Progress in Neuro-psychopharmacology & Biological Psychiatry | | 2021 | 397 | 2,085 | ||
| Intranasal oxytocin for negative symptoms of schizophrenia: systematic review, meta-analysis and dose-response meta-analysis of randomized controlled trials | International Journal of Neuropsychopharmacology | | 2021 | 297 | 281 | ||
| Cannabis, nicotine and the negative symptoms of schizophrenia: Systematic review and meta-analysis of observational studies | Neuroscience and Biobehavioral Reviews | | 2020 | 356 | 224 | ||
| Meditation-based mind-body therapies for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis | Schizophrenia Research | | 2019 | 306 | 0 | ||
| Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials | Journal of Clinical Psychopharmacology | | 2019 | 347 | 1 | ||
| Physical exercise for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis | General Hospital Psychiatry | | 2019 | 450 | 0 | ||
| Sexual Identity Disorder and Psychosis in Klinefelter Syndrome: A Synthesis of Literature and a Case Report | The journal of nervous and mental disease | | 2019 | 272 | 0 |
